Skip to main content

Mixed Amphetamine Salts Immediate-Release Tablet Use: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
mixed amphetamine salts immediate-release tablets
Description

In this request, we examined utilization patterns of mixed amphetamine salts immediate-release tablets. Patient cohorts were assessed with an inclusion requirement of a diagnosis of narcolepsy/attention deficit hyperactivity disorder (ADHD).

The study period includes data from January 1, 2013 – March 31, 2019. We executed this request on IBM® MarketScan® Research Databases on September 23, 2020. This analysis includes two reports:

  • Report 1: This report details utilization of mixed amphetamine salts immediate-release tablets for ten cohorts, by product manufacturer. 

  • Report 2: This reports details utilization of mixed amphetamine salts immediate-release tablets for an additional ten cohorts, by product manufacturer.

Deliverables (2)
Sentinel Query Builder Report: Mixed Amphetamine Salts Immediate-Release Tablet Use: A Descriptive Analysis, Report 1 Sentinel Query Builder Report: Mixed Amphetamine Salts Immediate-Release Tablet Use: A Descriptive Analysis, Report 2
Additional Details
FDA Center
CDER
Time Period
January 1, 2013 - March 31, 2019
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Merative™ MarketScan® Research Databases (formerly IBM® MarketScan®)
Related Links
Sentinel Drug Study: Mixed Amphetamine Salts & Switching Patterns